Boehringer Ingelheim (Sweden)

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

Hans‐Christoph Diener, Ralph L. Sacco, Salim Yusuf et al. · The Lancet Neurology · 2008 · 353 citations · Full text

Thrombosis, Cardiovascular Disease, Ischemic Stroke +15

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Joachim Stangier, Bengt I. Eriksson, Ola E. Dahl et al. · The Journal of Clinical Pharmacology · 2005 · 290 citations

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Bengt I. Eriksson, O.E. Dahl, Lennart Ahnfelt et al. · Journal of Thrombosis and Haemostasis · 2004 · 202 citations · Full text

Thrombosis, Dabigatran Etexilate, Hematology +6

Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure

Gianluigi Savarese, Ola Vedin, Domenico D’Amario et al. · JACC Heart Failure · 2019 · 197 citations · Full text

Heart Failure, Cardiovascular Epidemiology, Cardiovascular Disease +7

Specific barriers to the conduct of randomized trials

Lelia Duley, Karen H. Antman, Joseph P. Arena et al. · Clinical Trials · 2008 · 176 citations

Education, Quasi-experiment, Research Ethics +18